Vifor Pharma AG
VIFN | SW
Overview
Corporate Details
- ISIN(s):
- CH0364749348
- LEI:
- 529900KO6CN2D9OE1F19
- Country:
- Switzerland
- Address:
- Rechenstrasse 37, 9014 St. Gallen
- Website:
- https://www.viforpharma.com/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Vifor Pharma is a world leader in the discovery, development, manufacturing and marketing of pharmaceutical products for the treatment of iron deficiency. The company also offers a diversified portfolio of prescription medicines as well as non-prescription medicines. The Group also has a focus on the management of conditions in nephrology, cardiology and rare diseases. Vifor Pharma's operational headquarters are in Zurich, Switzerland, and the company has an increasingly global presence and a broad network of affiliates and partners around the world.
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-03-09 | N/A | Executive member | Sell | None | 4,335,210.00 CHF |
| 2022-03-09 | N/A | Non-Executive member | Sell | None | 1,951,125.00 CHF |
| 2022-03-09 | N/A | Non-Executive member | Sell | None | 1,851,300.00 CHF |
| 2022-03-09 | N/A | Executive member | Sell | None | 1,535,160.00 CHF |
| 2022-03-09 | N/A | Non-Executive member | Sell | None | 1,450,515.00 CHF |
| 2022-03-09 | N/A | Executive member | Sell | None | 920,205.00 CHF |
| 2022-03-09 | N/A | Executive member | Sell | None | 530,310.00 CHF |
| 2022-03-09 | N/A | Non-Executive member | Sell | None | 382,140.00 CHF |
| 2022-03-09 | N/A | Non-Executive member | Sell | None | 330,495.00 CHF |
| 2022-03-09 | N/A | Executive member | Sell | None | 287,925.00 CHF |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
KANABO GROUP PLC | United Kingdom | KNB | |
|
Karo Pharma AB | Sweden | KARO | |
|
Kinarus Therapeutics Holding AG | Switzerland | KNRS | |
|
Klaria Pharma Holding AB | Sweden | KLAR | |
|
Kolinpharma | Italy | KIP | |
|
Krka | Slovenia | KRKG | |
|
Kyivmedpreparat | Ukraine | KMED | |
|
Labiana S.A. | Spain | LAB | |
|
Labocanna Spolka Akcyjna | Poland | LCN | |
|
Laboratorio Farmaceutico Erfo | Italy | ERFO |